Keytruda (Pembrolizumab) Injection – 100 mg/4 mL
Immunotherapy for advanced cancers (checkpoint inhibitor).
Description
Keytruda (pembrolizumab) is a monoclonal antibody used in cancer immunotherapy for melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and more. It works by blocking PD-1 pathway to enhance T-cell immune response.
Reviews (0)
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.